Effect of Intrathecal Bupivacaine Temperature Variation on Prophylaxis of Shivering in Urologic P… (NCT07081516) | Clinical Trial Compass
CompletedNot Applicable
Effect of Intrathecal Bupivacaine Temperature Variation on Prophylaxis of Shivering in Urologic Patients Undergoing Spinal Anesthesia
Egypt96 participantsStarted 2025-04-01
Plain-language summary
The aim of this study is to evaluate the effect of temperature variation of injected intrathecal bupivacaine on prophylaxis of post-spinal shivering in urological patients undergoing spinal anaesthesia.
Who can participate
Age range18 Years – 60 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* 1\. Adult patients scheduled for urological procedures under spinal anaesthesia. 2. Patient age ranges from 18 to 60 years. 3. American Society of Anesthesiologists (ASA) physical status class I or II.
Exclusion Criteria:
* 1\. Patient's refusal of regional block. 2. Patients with neurological disorders, increased intracranial pressure, convulsive disorders, autonomic neuropathies, psychological disorders, or those lacking cooperation.
3\. Patients with anatomical abnormalities, skin lesions, wounds, or infection at the site of injection, or general infection.
4\. Patients with bleeding disorders defined as (INR\>1.4) and/or (platelet count \< 100,000/µL).
5\. Patients with known hypersensitivity to any of the study drugs. 6. Patients with renal impairment. 7. Patients with hepatic disease e.g. severe liver cell failure, or hepatic malignancy, or hepatic enlargement.
8\. Patients with failed, or partial spinal block.
What they're measuring
1
Incidence of Shivering
Timeframe: starting from the time of the spinal injection (T0) till the discharge from the PACU